The effects of 12 weeks of high-intensity interval training and moderate-intensity continuous training on FGF21, irisin, and myostatin in men with type 2 diabetes mellitus

References

• Aandstad, A., K. Holtberget, R. Hageberg, I. Holme, and S. A. Anderssen. 2014. “Validity and Reliability of Bioelectrical Impedance Analysis and Skinfold Thickness in Predicting Body Fat in Military Personnel.” Military Medicine 179 (2): 208–217. https://doi.org/10.7205/MILMED-D-12-00545
   PubMed Web of Science ®Google Scholar
• Amri, J., M. Parastesh, M. Sadegh, S. Latifi, and M. Alaee. 2019. “High-Intensity Interval Training Improved Fasting Blood Glucose and Lipid Profiles in Type 2 Diabetic Rats More than Endurance Training; Possible Involvement of Irisin and Betatrophin.” Physiology International 106 (3): 213–224. https://doi.org/10.1556/2060.106.2019.24
   PubMed Web of Science ®Google Scholar
• Arabzadeh, E., Z. Samadian, A. Tofighi, and J. Tolouei Azar. 2020. “Alteration of Follistatin-like 1, Neuron-Derived Neurotrophic Factor, and Vascular Endothelial Growth Factor in Diabetic Cardiac Muscle after Moderate-Intensity Aerobic Exercise with Insulin.” Sport Sciences for Health 16 (3): 491–499. https://doi.org/10.1007/s11332-020-00631-9
   Google Scholar
• Archundia-Herrera, C., M. Macias-Cervantes, B. Ruiz-Muñoz, K. Vargas-Ortiz, C. Kornhauser, and V. Perez-Vazquez. 2017. “Muscle Irisin Response to Aerobic vs HIIT in Overweight Female Adolescents.” Diabetology & Metabolic Syndrome 9 (1): 101. https://doi.org/10.1186/s13098-017-0302-5
   PubMedGoogle Scholar
• Baczek, J., M. Silkiewicz, and Z. B. Wojszel. 2020. “Myostatin as a Biomarker of Muscle Wasting and Other Pathologies-State of the Art and Knowledge Gaps.” Nutrients 12 (8): 2401. https://doi.org/10.3390/nu12082401
   PubMed Web of Science ®Google Scholar
• Banitalebi, E., A. Kazemi, M. Faramarzi, S. Nasiri, and M. M. Haghighi. 2019. “Effects of Sprint Interval or Combined Aerobic and Resistance Training on Myokines in Overweight Women with Type 2 Diabetes: A Randomized Controlled Trial.” Life Sciences 217: 101–109. https://doi.org/10.1016/j.lfs.2018.11.062
   PubMed Web of Science ®Google Scholar
• Banu, K., B. Muaz, and O. Nilsel. 2018. “Irisin and Myostatin Responses to Acute High-Intensity Interval Exercise in Humans.” Hormone Molecular Biology and Clinical Investigation 35 (3): 20180008.
   Web of Science ®Google Scholar
• Boström, P. A., and J. M. Fernández-Real. 2014. “Metabolism: Irisin, the Metabolic Syndrome and Follistatin in Humans.” Nature Reviews Endocrinology 10 (1): 11–12. https://doi.org/10.1038/nrendo.2013.230
   PubMed Web of Science ®Google Scholar
• Chwalbinska-Moneta, J., H. Krysztofiak, A. Ziemba, K. Nazar, and H. Kaciuba-Uściłko. 1996. “Threshold Increases in Plasma Growth Hormone in Relation to Plasma Catecholamine and Blood Lactate Concentrations during Progressive Exercise in Endurance-Trained Athletes.” European Journal of Applied Physiology and Occupational Physiology 73 (1–2): 117–120. https://doi.org/10.1007/BF00262819
   PubMed Web of Science ®Google Scholar
• Colberg, S. R., R. J. Sigal, B. Fernhall, J. G. Regensteiner, B. J. Blissmer, R. R. Rubin, L. Chasan-Taber, et al. 2010. “Exercise and Type 2 Diabetes: The American College of Sports Medicine and the American Diabetes Association: joint Position Statement.” Diabetes Care 33 (12): e147–e67. https://doi.org/10.2337/dc10-9990
   PubMed Web of Science ®Google Scholar
• Colberg, S. R., R. J. Sigal, J. E. Yardley, M. C. Riddell, D. W. Dunstan, P. C. Dempsey, E. S. Horton, et al. 2016. “Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association.” Diabetes Care 39 (11): 2065–2079. https://doi.org/10.2337/dc16-1728
   PubMed Web of Science ®Google Scholar
• da Silva, D. E., A. J. Grande, L. Roever, G. Tse, T. Liu, G. Biondi-Zoccai, and J. M. de Farias. 2019. “High-Intensity Interval Training in Patients with Type 2 Diabetes Mellitus: A Systematic Review.” Current Atherosclerosis Reports 21 (2): 8. https://doi.org/10.1007/s11883-019-0767-9
   PubMed Web of Science ®Google Scholar
• Dianatinasab, A., R. Koroni, M. Bahramian, Z. Bagheri-Hosseinabadi, M. Vaismoradi, M. Fararouei, and S. Amanat. 2020. “The Effects of Aerobic, Resistance, and Combined Exercises on the Plasma Irisin Levels, HOMA-IR, and Lipid Profiles in Women with Metabolic Syndrome: A Randomized Controlled Trial.” Journal of Exercise Science & Fitness 18 (3): 168–176. https://doi.org/10.1016/j.jesf.2020.06.004
   PubMed Web of Science ®Google Scholar
• Dünnwald, T., A. Melmer, H. Gatterer, K. Salzmann, C. Ebenbichler, M. Burtscher, W. Schobersberger, et al. 2019. “Supervised Short-Term High-Intensity Training on Plasma Irisin Concentrations in Type 2 Diabetic Patients.” International Journal of Sports Medicine 40 (03): 158–164. https://doi.org/10.1055/a-0828-8047
   PubMedGoogle Scholar
• Eckardt, K., S. W. Gorgens, S. Raschke, and J. Eckel. 2014. “Myokines in Insulin Resistance and Type 2 Diabetes.” Diabetologia 57 (6): 1087–1099. https://doi.org/10.1007/s00125-014-3224-x
   PubMed Web of Science ®Google Scholar
• Fatouros, I. G. 2018. “Is Irisin the New Player in Exercise-Induced Adaptations or Not? A 2017 Update.” Clinical Chemistry and Laboratory Medicine 56 (4): 525–548. https://doi.org/10.1515/cclm-2017-0674
   PubMed Web of Science ®Google Scholar
• Froelicher, V. F., A. J. Thompson, I. Noguera, G. Davis, A. J. Stewart, and J. H. Triebwasser. 1975. “Prediction of Maximal Oxygen Consumption: Comparison of the Bruce and Balke Treadmill Protocols.” Chest 68 (3): 331–336. https://doi.org/10.1378/chest.68.3.331
   PubMed Web of Science ®Google Scholar
• Gao, R.-Y., B.-G. Hsu, D.-A. Wu, J.-S. Hou, and M.-C. Chen. 2019. “Serum Fibroblast Growth Factor 21 Levels Are Positively Associated with Metabolic Syndrome in Patients with Type 2 Diabetes.” International Journal of Endocrinology 2019: 1–8. https://doi.org/10.1155/2019/5163245
   Web of Science ®Google Scholar
• García-Fontana, B., R. Reyes-García, S. Morales-Santana, V. Ávila-Rubio, A. Muñoz-Garach, P. Rozas-Moreno, and M. Muñoz-Torres. 2016. “Relationship between Myostatin and Irisin in Type 2 Diabetes Mellitus: A Compensatory Mechanism to an Unfavourable Metabolic State?” Endocrine 52 (1): 54–62. https://doi.org/10.1007/s12020-015-0758-8
   PubMed Web of Science ®Google Scholar
• García-Hermoso, A., R. Ramírez-Vélez, J. Díez, A. González, and M. Izquierdo. 2023. “Exercise Training-Induced Changes in Exerkine Concentrations May Be Relevant to the Metabolic Control of Type 2 Diabetes Mellitus Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Journal of Sport and Health Science 12 (2): 147–157. https://doi.org/10.1016/j.jshs.2022.11.003
   PubMed Web of Science ®Google Scholar
• Garneau, L., and C. Aguer. 2019. “Role of Myokines in the Development of Skeletal Muscle Insulin Resistance and Related Metabolic Defects in Type 2 Diabetes.” Diabetes & Metabolism 45 (6): 505–516. https://doi.org/10.1016/j.diabet.2019.02.006
   PubMed Web of Science ®Google Scholar
• Geng, L., B. Liao, L. Jin, Z. Huang, C. R. Triggle, H. Ding, J. Zhang, et al. 2019. “Exercise Alleviates Obesity-Induced Metabolic Dysfunction via Enhancing FGF21 Sensitivity in Adipose Tissues.” Cell Reports 26 (10): 2738–2752.e4. https://doi.org/10.1016/j.celrep.2019.02.014
   PubMed Web of Science ®Google Scholar
• Haghighi, A. H., M. Hajinia, R. Askari, S. Abbasian, and G. Goldfied. 2022. “Effect of High-Intensity Interval Training and High-Intensity Resistance Training on Irisin and Fibroblast Growth Factor 21 in Men with Overweight and Obesity.” Canadian Journal of Physiology and Pharmacology 100 (9): 937–944. https://doi.org/10.1139/cjpp-2021-0712
   PubMed Web of Science ®Google Scholar
• Hansen, J. S., B. K. Pedersen, G. Xu, R. Lehmann, C. Weigert, and P. Plomgaard. 2016. “Exercise-Induced Secretion of FGF21 and Follistatin Are Blocked by Pancreatic Clamp and Impaired in Type 2 Diabetes.” The Journal of Clinical Endocrinology & Metabolism 101 (7): 2816–2825. https://doi.org/10.1210/jc.2016-1681
   PubMed Web of Science ®Google Scholar
• Heggelund, J., G. E. Nilsberg, J. Hoff, G. Morken, and J. Helgerud. 2011. “Effects of High Aerobic Intensity Training in Patients with Schizophrenia—a Controlled Trial.” Nordic Journal of Psychiatry 65 (4): 269–275. https://doi.org/10.3109/08039488.2011.560278
   PubMed Web of Science ®Google Scholar
• Helgerud, J., K. Høydal, E. Wang, T. Karlsen, P. Berg, M. Bjerkaas, T. Simonsen, et al. 2007. “Aerobic High-Intensity Intervals Improve VO2max More than Moderate Training.” Medicine & Science in Sports & Exercise 39 (4): 665–671. https://doi.org/10.1249/mss.0b013e3180304570
   PubMed Web of Science ®Google Scholar
• Ju, C.-R., and R.-C. Chen. 2012. “Serum Myostatin Levels and Skeletal Muscle Wasting in Chronic Obstructive Pulmonary Disease.” Respiratory Medicine 106 (1): 102–108. https://doi.org/10.1016/j.rmed.2011.07.016
   PubMed Web of Science ®Google Scholar
• Junichiro, S., Z. C. Mark, and B. Amos. 2017. “FGF21-Receptor Agonists: An Emerging Therapeutic Class for Obesity-Related Diseases.” Hormone Molecular Biology and Clinical Investigation 30 (2): 20170002.
   Google Scholar
• Kazemi, F. 2019. “Myostatin Alters with Exercise Training in Diabetic Rats; Possible Interaction with Glycosylated Hemoglobin and Inflammatory Cytokines.” Cytokine 120: 99–106. https://doi.org/10.1016/j.cyto.2019.04.012
   PubMed Web of Science ®Google Scholar
• Kharitonenkov, A., T. L. Shiyanova, A. Koester, A. M. Ford, R. Micanovic, E. J. Galbreath, G. E. Sandusky, et al. 2005. “FGF-21 as a Novel Metabolic Regulator.” Journal of Clinical Investigation 115 (6): 1627–1635. https://doi.org/10.1172/JCI23606
   PubMed Web of Science ®Google Scholar
• Kordi, M., S. Khoramshahi, S. Eshghi, A. Gaeeni, and A. Moosakhani. 2020. “The Effect of High Intensity Interval Training on Some Atrophic and anti-Atrophic Gene Expression in Rat Skeletal Muscle with Diabetes.” Science & Sports 35 (3): e75–e81. https://doi.org/10.1016/j.scispo.2019.04.003
   Web of Science ®Google Scholar
• Leung, P. S. 2017. “The Potential of Irisin as a Therapeutic for Diabetes.” Future Medicinal Chemistry 9 (6): 529–532.
   PubMed Web of Science ®Google Scholar
• Maillard, F., S. Rousset, B. Pereira, A. Traore, P. de Pradel Del Amaze, Y. Boirie, M. Duclos, et al. 2016. “High-Intensity Interval Training Reduces Abdominal Fat Mass in Postmenopausal Women with Type 2 Diabetes.” Diabetes & Metabolism 42 (6): 433–441. https://doi.org/10.1016/j.diabet.2016.07.031
   PubMed Web of Science ®Google Scholar
• Matthews, D. R., J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner. 1985. “Homeostasis Model Assessment: insulin Resistance and Beta-Cell Function from Fasting Plasma Glucose and Insulin Concentrations in Man.” Diabetologia 28 (7): 412–419. https://doi.org/10.1007/BF00280883
   PubMed Web of Science ®Google Scholar
• Mohammad Rahimi, G. R., K. Hejazi, and M. Hofmeister. 2022. “ The Effect of Exercise Interventions on Irisin Level: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” EXCLI Journal 21: 524–539.
   PubMedGoogle Scholar
• Motahari Rad, M., N. Bijeh, S. R. Attarzadeh Hosseini, and A. Raouf Saeb. 2023. “The Effect of Two Concurrent Exercise Modalities on Serum Concentrations of FGF21, Irisin, Follistatin, and Myostatin in Men with Type 2 Diabetes Mellitus.” Archives of Physiology and Biochemistry 129 (2): 424–433. https://doi.org/10.1080/13813455.2020.1829649
   PubMedGoogle Scholar
• Motahari Rad, M., N. Bijeh, S. R. Attarzadeh Hosseini, and A. Raouf Saeb. 2021. “The Impact of Different Modes of Exercise Training on Irisin: A Systematic Review and Meta-Analysis Research.” Journal of Advances in Medical and Biomedical Research 29 (134): 125–138. https://doi.org/10.30699/jambs.29.134.125
   Google Scholar
• Nejati, R., N. Bijeh, M. M. Rad, and S. A. Hosseini. 2022. “The Impact of Different Modes of Exercise Training on GLP-1: A Systematic Review and Meta-Analysis Research.” International Journal of Diabetes in Developing Countries 42 (1): 40–48. https://doi.org/10.1007/s13410-021-00950-8
   Web of Science ®Google Scholar
• Tine Kartinah, N., I. Rosalyn Sianipar, Nafi’ah, and Rabia. 2018. The Effects of Exercise Regimens on Irisin Levels in Obese Rats Model: Comparing High-Intensity Intermittent with Continuous Moderate-Intensity Training. BioMed Research international 2018:4708287. https://doi.org/10.1155/2018/4708287
   PubMed Web of Science ®Google Scholar
• Oldham, J. M., C. C. Osepchook, F. Jeanplong, S. J. Falconer, K. G. Matthews, J. V. Conaglen, D. F. Gerrard, et al. 2009. “The Decrease in Mature Myostatin Protein in Male Skeletal Muscle is Developmentally Regulated by Growth Hormone.” The Journal of Physiology 587 (3): 669–677. https://doi.org/10.1113/jphysiol.2008.161521
   PubMed Web of Science ®Google Scholar
• Opoku, Y. K., Z. Liu, J. Afrifa, M. H. Khoso, G. Ren, and D. Li. 2020. “Therapeutic Role of Fibroblast Growth Factor 21 (FGF21) in the Amelioration of Chronic Diseases.” International Journal of Peptide Research and Therapeutics 26 (1): 107–119. https://doi.org/10.1007/s10989-019-09820-8
   Web of Science ®Google Scholar
• Panahi, Y., S. Bonakdaran, M. A. Yaghoubi, M. R. Keramati, M. Haratian, and A. Sahebkar. 2016. “Serum Levels of Fibroblast Growth Factor 21 in Type 2 Diabetic Patients.” Acta Endocrinologica 12 (3): 257–261. https://doi.org/10.4183/aeb.2016.257
   Google Scholar
• Park, H.-S., H. C. Kim, D. Zhang, H. Yeom, and S.-K. Lim. 2019. “The Novel Myokine Irisin: clinical Implications and Potential Role as a Biomarker for Sarcopenia in Postmenopausal Women.” Endocrine 64 (2): 341–348. https://doi.org/10.1007/s12020-018-1814-y
   PubMed Web of Science ®Google Scholar
• Planella-Farrugia, C., F. Comas, M. Sabater-Masdeu, M. Moreno, J. M. Moreno-Navarrete, O. Rovira, W. Ricart, et al. 2019. “Circulating Irisin and Myostatin as Markers of Muscle Strength and Physical Condition in Elderly Subjects.” Frontiers in Physiology 10: 871. https://doi.org/10.3389/fphys.2019.00871
   PubMed Web of Science ®Google Scholar
• Porflitt-Rodríguez, M., V. Guzmán-Arriagada, R. Sandoval-Valderrama, C. S. Tam, F. Pavicic, P. Ehrenfeld, and S. Martínez-Huenchullán. 2022. “Effects of Aerobic Exercise on Fibroblast Growth Factor 21 in Overweight and Obesity. A Systematic Review.” Metabolism 129: 155137. https://doi.org/10.1016/j.metabol.2022.155137
   PubMed Web of Science ®Google Scholar
• Pourvaghar, M. J., and M. E. Bahram. 2018. “The Role of Chemerin and Myostatin after Physical Activity.” World Academy of Science, Engineering and Technology, International Journal of Sport and Health Sciences 5 (2): 394–397.
   Google Scholar
• Safarimosavi, S., H. Mohebbi, and H. Rohani. 2021. “High-Intensity Interval vs. Continuous Endurance Training: Preventive Effects on Hormonal Changes and Physiological Adaptations in Prediabetes Patients.” Journal of Strength and Conditioning Research 35 (3): 731–738. https://doi.org/10.1519/JSC.0000000000002709
   PubMed Web of Science ®Google Scholar
• Schjerve, I. E., G. A. Tyldum, A. E. Tjønna, T. Stølen, J. P. Loennechen, H. E. M. Hansen, P. M. Haram, et al. 2008. “Both Aerobic Endurance and Strength Training Programmes Improve Cardiovascular Health in Obese Adults.” Clinical Science 115 (9): 283–293. https://doi.org/10.1042/CS20070332
   PubMed Web of Science ®Google Scholar
• Shabkhiz, F., M. Khalafi, S. Rosenkranz, P. Karimi, and K. Moghadami. 2021. “Resistance Training Attenuates Circulating FGF-21 and Myostatin and Improves Insulin Resistance in Elderly Men with and without Type 2 Diabetes Mellitus: A Randomised Controlled Clinical Trial.” European Journal of Sport Science 21 (4): 636–645. https://doi.org/10.1080/17461391.2020.1762755
   PubMed Web of Science ®Google Scholar
• Singh, R., M. Braga, and S. Pervin. 2014. “Regulation of Brown Adipocyte Metabolism by Myostatin/Follistatin Signaling.” Frontiers in Cell and Developmental Biology 2: 60. https://doi.org/10.3389/fcell.2014.00060
   PubMed Web of Science ®Google Scholar
• Son, J. S., S. A. Chae, E. D. Testroet, M. Du, and H.-P. Jun. 2018. “Exercise-Induced Myokines: A Brief Review of Controversial Issues of This Decade.” Expert Review of Endocrinology & Metabolism 13 (1): 51–58. https://doi.org/10.1080/17446651.2018.1416290
   PubMed Web of Science ®Google Scholar
• Taniguchi, H., K. Tanisawa, X. Sun, T. Kubo, and M. Higuchi. 2016. “Endurance Exercise Reduces Hepatic Fat Content and Serum Fibroblast Growth Factor 21 Levels in Elderly Men.” The Journal of Clinical Endocrinology & Metabolism 101 (1): 191–198. https://doi.org/10.1210/jc.2015-3308
   PubMed Web of Science ®Google Scholar
• Tezze, C., V. Romanello, and M. Sandri. 2019. “FGF21 as Modulator of Metabolism in Health and Disease.” Frontiers in Physiology 10: 419–419. (https://doi.org/10.3389/fphys.2019.00419
   PubMed Web of Science ®Google Scholar
• Vingren, J. L., W. J. Kraemer, N. A. Ratamess, J. M. Anderson, J. S. Volek, and C. M. Maresh. 2010. “Testosterone Physiology in Resistance Exercise and Training.” Sports Medicine 40 (12): 1037–1053. https://doi.org/10.2165/11536910-000000000-00000
   PubMed Web of Science ®Google Scholar
• Xiao, Y., L. Liu, A. Xu, P. Zhou, Z. Long, Y. Tu, X. Chen, et al. 2015. “Serum Fibroblast Growth Factor 21 Levels Are Related to Subclinical Atherosclerosis in Patients with Type 2 Diabetes.” Cardiovascular Diabetology 14 (1): 72. https://doi.org/10.1186/s12933-015-0229-9
   PubMedGoogle Scholar
• Xiong, Y., Y. Chen, Y. Liu, and B. Zhang. 2020. “Moderate-Intensity Continuous Training Improves FGF21 and KLB Expression in Obese Mice.” Biochemistry 85 (8): 938–946. https://doi.org/10.1134/S000629792008009X
   PubMed Web of Science ®Google Scholar
• Yang, D., Y. Yang, Y. Li, and R. Han. 2019. “Physical Exercise as Therapy for Type 2 Diabetes Mellitus: From Mechanism to Orientation.” Annals of Nutrition and Metabolism 74 (4): 313–321. https://doi.org/10.1159/000500110
   PubMed Web of Science ®Google Scholar
• Zaki, S., S. Sharma, and H. Vats. 2023. “Effectiveness of Concurrent Exercise Training in People with Type 2 Diabetes: A Systematic Review and Meta-Analysis.” Physiotherapy Theory and Practice. Advance online publication. https://doi.org/10.1080/09593985.2023.2225717
   Web of Science ®Google Scholar
• Zhou, X., M. Xu, J. L. Bryant, J. Ma, and X. Xu. 2019. “Exercise-Induced Myokine FNDC5/Irisin Functions in Cardiovascular Protection and Intracerebral Retrieval of Synaptic Plasticity.” Cell & Bioscience 9 (1): 32. https://doi.org/10.1186/s13578-019-0294-y
   PubMed Web of Science ®Google Scholar